Host: Mark Socinski, MD Guest: Edward B. Garon, MD, MS In the treatment of EGFR-mutated advanced non-small cell lung cancer (NSCLC), when is an EGFR TKI not enough? Answer: When you don’t have all of the information. Digging deeper into the specifi

Host: Jennifer Caudle, DO Guest: Drew Weissman, MD, PhD mRNA vaccines are one of the latest developments in medicine, but researchers have been evaluating mRNA technology for years. One of those researchers, Dr. Dr. Drew Weissman, Professor of Medi

Guest: Peter Goadsby, MD, PhD, DSc Guest: Kathleen B. Mullin, MD Women with migraine have unique needs that often remain undermanaged. Have you taken a critical look at the standard of care and how current treatment strategies have recently shifted

Host: Roger S. McIntyre, MD, FRCPC Guest: Charles L. Raison, MD This patient-provider role play webcast is designed to provide clinicians with effective communication strategies for discussing long-acting injectable antipsychotics with patients in

Host: Roger S. McIntyre, MD, FRCPC Guest: Martha Sajatovic, MD This Expert Exchange webcast is designed to help clinicians determine the appropriate time to initiate LAI therapy in patients with bipolar disorder, and how to discuss that treatment d

Host: Jeffrey S. Weber, MD, PhD Approximately half of metastatic cutaneous melanomas carry mutations in BRAF, leading to more aggressive disease. For patients with BRAF V600–activating mutations, treatment options now include the use of combination t

Host: Gregg C. Fonarow, MD Guest: Andrew J. S. Coats, MD Rapid initiation and up-titration of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy is critical in the management of heart failure, especially given the prevalence of comorbid

Guest: Phil Lieberman, MD Host: Jennifer Caudle, DO Are you familiar with the role of serum tryptase testing in diagnosing idiopathic anaphylaxis and mastocytosis? What role does serum tryptase play in the ongoing management of patients who have an

Host: Keith C. Ferdinand, MD Guest: Marco Metra, MD There is a substantial gap between the guideline recommendations for treatment and the real-world prescribing patterns of RAASi therapy. This disconnect results in worse cardiorenal outcomes and h

Host: Michael E. Wechsler, MD, MMSc Guest: Eileen Wang, MD, MPH In this session, National Jewish Health faculty experts will discuss a new paradigm of severe asthma pathophysiology and potential treatment targets that may impact patients with non-a